These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37728023)

  • 1. Stent Graft vs Drug-Coated Balloon in Endovascular Treatment of Complex Femoropopliteal Artery Lesions: A 2-Center Experience.
    Ye M; Ni Q; Zhu Y; Du Y; Wang Y; Guo X; Zhang L; Feng Z
    J Endovasc Ther; 2023 Sep; ():15266028231201097. PubMed ID: 37728023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
    J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Eluting Stent vs. Drug Coated Balloon for Native Femoropopliteal Artery Disease: A Two Centre Experience.
    Lee YJ; Kook H; Ko YG; Yu CW; Joo HJ; Ahn CM; Choi D
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):287-295. PubMed ID: 33223281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single-Center Study on the Outcomes of Target Limb Revascularization in Femoropopliteal Lesions Treated With Drug Coated Balloons and Bare Metal Stents.
    Linehan V; Doyle M; Barrett B; Gullipalli R
    J Endovasc Ther; 2022 Dec; 29(6):948-955. PubMed ID: 34986705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Balloon Pre-dilatation Techniques on Drug-Coated Balloon Therapy for Femoropopliteal Artery Disease: Six-Month Results From the CIVILIAN Registry.
    Ye M; Ni Q; He C; Shi Z; Shi W; Zhu J; Li L; Wu Z
    J Endovasc Ther; 2024 Feb; ():15266028241231036. PubMed ID: 38357875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
    Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.
    Liistro F; Angioli P; Porto I; Ducci K; Falsini G; Ventoruzzo G; Ricci L; Scatena A; Grotti S; Bolognese L
    J Am Coll Cardiol; 2019 Jul; 74(2):205-215. PubMed ID: 31296293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
    Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
    J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease.
    Ma H; Zhang X; Li J; Li Q; Li W; Jiao Y; Jiang J; He C; He Z; Li W; Zhang T; Zhang X
    Ann Vasc Surg; 2022 Apr; 81():316-323. PubMed ID: 34762999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions.
    Li L; Tong Z; Cui S; Guo L
    Wideochir Inne Tech Maloinwazyjne; 2023 Mar; 18(1):166-172. PubMed ID: 37064559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm Results of Drug-Coated Balloon and Bare Metal Stent in the Treatment of TASCII C/D Femoropopliteal Artery Occlusive Disease: A Retrospective Multicenter Study.
    Xiao L; Gu S; Chen Y; Zhang X; Wang Y; Dai X
    J Endovasc Ther; 2023 Nov; ():15266028231209932. PubMed ID: 37978877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm.
    Dubosq-Lebaz M; Fels A; Chatellier G; Gouëffic Y
    J Endovasc Ther; 2023 Sep; ():15266028231202709. PubMed ID: 37776300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
    Wei L; Guo J; Guo L; Qi L; Cui S; Tong Z; Hou P; Gu Y
    Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.